What Matters in Survival, Treatment of Lymphoid Cancers?

Oncologists balance the most effective treatment against the likelihood of adverse effects for every patient with cancer. Generally, the assumption is that older patients and those with more comorbidities and poorer performance status will experience more negative effects, including potentially fatal toxicity, from aggressive treatment. A study presented at the American Society of Clinical Oncology annual meeting in June calls into question this assumption for at least some patients and specific malignancies.

Choosing the Right Regimen for Elderly Patients with Advanced RCC

Most clinical trials provide limited guidance on the appropriate treatment of patients seen in clinical practice. Particularly in oncology, participants in trials tend to be significantly younger and in substantially better health than the average patient. Renal cell carcinoma (RCC) provides a clear example of the challenge.

nCRC, Sequencing Offers Better Guidance than Staining When Results Differ

Chemotherapy has long been a component in the first-line treatment for advanced or metastatic colorectal cancer (mCRC). A number of studies in recent years indicate that a subset of patients with specific genetic mutations do not respond well to the recommended 5-fluorouracil-based regimens, such as FOLFOX (5-FU, oxaliplatin, and leucovorin) or FOLFIRI (5-FU, irinotecan, and leucovorin) alone or in combination with other agents.

Response Rates for Waldenström Macroglobulinemia Improve With Use of New First-Line, Better-Tolerated Treatments

As the number of first-line treatments for Waldenström Macroglobulinemia increased, older adults experienced marked improvements in survival Among older patients, median progression-free survival improved from 28.3 months in the early era to 63.3 months in the modern era, according to a new study. Younger patients, on the other hand, showed almost no improvement in median progression-free survival between eras, the authors pointed out.

Retention Rates Remain Low for Substance Use Disorder Programs

A common explanation for the high dropout rate and failure of a substance use disorder program is that patients fear symptoms of opioid withdrawal. A new study suggested that is for good reason, especially since patients who are exposed to full opioid agonists chronically are recommended to already be experiencing moderate withdrawal symptoms before they can get drugs to alleviate the symptoms. That’s why the FDA has approved new alternatives, including auricular stimulators, to help patients through the difficult withdrawal symptoms.

COVID-19 Infection Increased Suicide Attempts in Some Younger Veterans With Schizophrenic, Schizoaffective Disorder

Authors of a new study strongly urged that patients with schizophrenia or schizoaffective disorder who have a history of suicide attempt and are younger than 59 or obese, should be monitored closely during the COVID-19 pandemic. They warned of the possibility of symptom exacerbation in those patients when they have severe COVID-19 since postmortem examination of brains in that cohort have revealed infection-related impaired brain neurotransmission.

Low Muscle Mass Along with High Tumor IL-6 Expression Strongly Associated with Mortality in Renal Cancer

The combination of low muscle mass and high tumor IL-6 expression predicts early death in patients with clear cell renal cell carcinoma, according to a new study. As with some other malignancies, cachexia is a major cause of mortality in ccRCC, the authors warned, noting that the combination of low muscle mass and high tumor IL-6 expression should raise alarms.

The Fungus Really Is Among Us: Its Role in Airway Disease, Nasal Polyps

What is the role of fungus in allergic airway diseases? VA researchers found that many conditions, including chronic rhinosinusitis (CRS), allergic fungal rhinosinusitis, asthma, allergic bronchopulmonary mycosis/aspergillosis, and cystic fibrosis (CF have a shared immunological signature. In some cases, nasal polyps can occur.

A Rare Cancer Prompts Sleuthing at the VA; New Options for MDS

VA researchers solved a mystery involving younger veterans who developed unusual and deadly cancers. They determined that patients currently using certain drugs, thiopurines, had triple the risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) on an adjusted basis compared to those never exposed. The risks resolved with discontinuation.

Early Colonoscopy in Veterans With IBD Lowers Overall Mortality

Well-timed colonoscopy appears to improve overall survival in inflammatory bowel disease patients, but many VA patients aren’t getting screened regularly. A new study supported current VA practice guidelines that recommend colonoscopy intervals from one year to three years among patients with IBD who have extensive colitis or left-sided colitis.

Risk Factors Change for HCC With More Effective Hepatitis C Treatment

Risk factors for hepatocellular carcinoma have undergone dramatic changesin recent years. Metabolic conditions such as obesity and diabetes, as well as associated nonalcoholic fatty liver disease, now sit at the top of the list. Alcohol use disorders also are on the increase, fueling alcoholic liver disease and alcoholic cirrhosis. At the same time, however, with more effective treatment and prevention, hepatitis C and hepatitis B infections have decreased in prevalence.

VA Researchers Look at Role of Estrogen, Menopause In Elevated Rates of Glaucoma in Women

VA Researchers Look at Role of Estrogen, Menopause In Elevated Rates of Glaucoma in Women

Women represented less than 10% of U.S. veterans in 2017, according to the National Center for Veterans Analysis and Statistics, but the number of women veterans receiving VHA care has increased by 22.1%, from 423,642 in 2014 to 517,241 in 2018 and is predicted to burgeon even more in the future. That’s why studies such as one examining the role of estrogen and menopause in glaucoma are so important to the VA.

In-hospital Continuous Glucose Monitoring Protects Patients, HCPs

Hyperglycemia and diabetes are common in hospitalized patients. Managing that amid the restrictions of the COVID-19 pandemic, including the more recent staff shortages, has been extremely difficult at the VA and elsewhere. Increased use of continuous glucose monitoring has helped the situation.